The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.

Uzma KhanHelena HuergaAamir J KhanCarole D MitnickCatherine HewisonFrancis VaraineMathieu BastardMichael RichMolly F FrankeSidney AtwoodPalwasha Y KhanKwonjune J Seung

Published in: BMC infectious diseases (2019)

This study was registered on 24 August 2017 at clincaltrials.gov (Registration number: NCT03259269).

Keyphrases

multidrug resistant
study protocol
randomized controlled trial
drug resistant
mycobacterium tuberculosis
clinical trial
cross sectional
open label
double blind